| Board of
Directors |
Chairman : Munjed M.
Sukhtian
Executive General Manager: Qais M. Sukhtian |
| Paid
Capital
|
$ 4.2 Million US |
| Personnel |
336 employees |
| Company
Classification |
Private limited |
|
Markets |
Saudi Arabia, United
Arab Emirates, Oman, Qatar, Bahrain, Iraq, Algeria, Yemen, Libya, Romania,
Lebanon, Kuwait, Egypt, Tunisia, Sudan, Ethiopia, Russia, Bulgaria, Germany,
Belgium, Spain, Holland, Austria, Greece, Brazil, Finland, Portugal, Czech,
Denmark, Switzerland, France, Liechtenstein, South Africa and SriLanka |
|
Sister Companies |
Tabuk Pharmaceutical
Mfg. Co. (KSA),
Jordan Chemical Laboratory (Palestine). |
|
Lines of Production |
Solids: Tablets, Soft and Hard gelatin
capsules.
Liquids: Syrups, Solutions, Shampoos and (dry) suspensions.
Semi-solids: Creams, Ointments and Gels.
Suppositories.
Ovules
Vials: IV and IM
Transdermal patches. |
| Therapeutic Categories |
Antibiotics, Antifungals,
Antiprotozoals, Cardiovascular, CNS, Respiratory and Gastrointestinal
products, Anti-inflammatories / antirheuhmatics / Analgesics, Antiallergics,
Anti-asthmatics, Oral hypoglycemics, Vitamins & minerals, Immunosuppressants,
and others (Nicotine & Fentanyl transdermal patches). |
|
Certification |
European GMP (2000),
Brazilian GMP (2004) |
| Fields of
Cooperation |
Contract manufacturing
licensing, exchange of technology |
| Licenses
|
GSK, Mundipharma AG, ICN,
Rhône-Poulenc Rorer, F. Trenka |
| Address |
Al-Raqeem, Nuzhat Sahab,
Public Security Housing Street, P.O. Box 69, Amman, 11591 Jordan |
| Telephone |
++ 962 6 416 2901-4 |
| Fax |
++ 962 6 416 2905 |
| E-mail |
info@upm.com.jo |
| Web Site |
www.united-pharmaceuticals.com |
|